Hairy Cell Leukemia

Justin Watts, Martin S. Tallman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter presents two case studies and series of question and answers on hairy cell leukemia (HCL). It commences with a discourse on how minimal residual disease (MRD) defined, and also MRD on portend relapse in HCL, and ends with the question on best front-line therapy in a symptomatic pregnant patient with HCL. The chapter also discusses on whether a patient relapses after a single cycle of cladribine and best therapeutic approach, and best treatment for patients with multiply relapsed HCL and a role for hematopoietic cell transplantation (HCT).

Original languageEnglish (US)
Title of host publicationCancer Consult: Expertise for Clinical Practice
PublisherWiley Blackwell
Pages220-225
Number of pages6
ISBN (Print)9781118589199, 9781118589212
DOIs
StatePublished - Jun 20 2014
Externally publishedYes

    Fingerprint

Keywords

  • Hairy cell leukemia (HCL)
  • Minimal residual disease (MRD)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Watts, J., & Tallman, M. S. (2014). Hairy Cell Leukemia. In Cancer Consult: Expertise for Clinical Practice (pp. 220-225). Wiley Blackwell. https://doi.org/10.1002/9781118589199.ch34